Consumer perception, knowledge, and uses of cannabidiol

Introduction The legalization of cannabidiol (CBD) across the United States, in varying degrees, has made CBD easily accessible to consumers for complementary and medical purposes. However, there is a paucity of scientific evidence on the benefits and risks of commercially available CBD. In the lite...

Full description

Saved in:
Bibliographic Details
Main Authors: Nguyen Cambrey PharmD (Author), Moeller Karen E. PharmD (Author), McGuire Michael PharmD (Author), Melton Brittany L. PharmD, PhD (Author)
Format: Book
Published: American Association of Psychiatric Pharmacists, 2023-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d80fa39a078f4e7eb22e153b4ba91f52
042 |a dc 
100 1 0 |a Nguyen Cambrey PharmD  |e author 
700 1 0 |a Moeller Karen E. PharmD  |e author 
700 1 0 |a McGuire Michael PharmD  |e author 
700 1 0 |a Melton Brittany L. PharmD, PhD  |e author 
245 0 0 |a Consumer perception, knowledge, and uses of cannabidiol 
260 |b American Association of Psychiatric Pharmacists,   |c 2023-10-01T00:00:00Z. 
500 |a 2168-9709 
500 |a 10.9740/mhc.2023.10.217 
520 |a Introduction The legalization of cannabidiol (CBD) across the United States, in varying degrees, has made CBD easily accessible to consumers for complementary and medical purposes. However, there is a paucity of scientific evidence on the benefits and risks of commercially available CBD. In the literature, 2 studies have gathered consumer perceptions and attitudes on cannabis products, specifically CBD, using survey-based questionnaires. This study aimed to build on the aforementioned studies in obtaining consumer perception and knowledge of CBD products using a national survey-based questionnaire. Methods Respondents were recruited through an anonymous, nationwide, online survey administered through Qualtrics in the United States from March 28 to April 30, 2021. The survey consisted of demographics, perceived efficacy and safety of CBD, and resources to obtain CBD information. The survey responses were reported using descriptive statistics along with median and interquartile range for the Likert portion. Results A total of 1158 respondents accessed the survey. The median age was 43 and 50% of respondents were female. The uses for CBD included neurological disorders, pulmonary conditions, gastrointestinal disorders, and chronic pain. The most commonly reported safety concern related to taking CBD was anxiety. Participants agreed that CBD is safe when used responsibly for medical use, and social media was the main source used to obtain information about CBD. Discussion Respondents who used CBD for a condition thought it was helpful; however, most of the adverse effects were rated as moderate to severe, requiring medical attention from a health care professional, hospital, or emergency room visit. 
546 |a EN 
690 |a cannabidiol 
690 |a consumer 
690 |a perception 
690 |a drug resources 
690 |a survey 
690 |a Neurosciences. Biological psychiatry. Neuropsychiatry 
690 |a RC321-571 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Mental Health Clinician, Vol 13, Iss 5, Pp 217-224 (2023) 
787 0 |n https://theijpt.org/doi/pdf/10.9740/mhc.2023.10.217 
787 0 |n https://doaj.org/toc/2168-9709 
856 4 1 |u https://doaj.org/article/d80fa39a078f4e7eb22e153b4ba91f52  |z Connect to this object online.